BRCA mutation does not change survival rate
This article was originally published in Clinica
In what could influence patient management, a New England Journal of Medicine (NEJM) study reports that breast cancer patients carrying either of the BRCA gene variants are at no higher risk of dying from the disease than non-carriers with breast cancer. In addition, carriers of the BRCA 1 mutation were more likely to respond well to chemotherapy than non-carriers.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.